EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sparsomycin inhibits translation through a conserved mechanism across all domains of life

Madhura N Paranjpe, Elodie C Leroy iD, Egor A Syroegin iD, Laurin Flemmich, Julia Thaler, Mélanie Gillard, Anthony Bougas, Georgia Kournoutou, George P Dinos, Thibaud T Renault iD, Ronald Micura iD, C Axel Innis iD und 1 weitere

Nucleic Acids Research · 10.08.2026 · 54 (15)

DOI: 10.1093/nar/gkag761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.08.2026. Verfasst von Madhura N Paranjpe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, United States. Hauptthemen laut MEDLINE: Ribosomes, Sparsomycin, Protein Synthesis Inhibitors, Protein Biosynthesis. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tyrolean Young Researchers Fund, Austrian Science Fund, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sparsomycin (SPA) is a broad-spectrum inhibitor of protein synthesis with activity across all three domains of life. Although SPA has long been known to target the ribosomal peptidyl transferase center (PTC), previous structural studies suggested that SPA binds differently to bacterial ribosomes compared to their archaeal and eukaryotic counterparts—an unexpected conclusion given the high evolutionary conservation of the ribosomal catalytic center. Here, we show that SPA inhibits a majority of elongation-competent bacterial ribosomal complexes and present X-ray crystal structures of Thermus thermophilus 70S ribosomes stalled by SPA at the initiation and early elongation stages of translation. These structures reveal that SPA binds to the bacterial ribosome in a manner essentially identical to that observed in archaeal and eukaryotic ribosomes, establishing a unified structural mechanism of SPA action across all domains of life. In this conserved binding mode, SPA occupies the A-site cleft of the PTC and forms an extensive network of interactions with universally conserved ribosomal RNA nucleotides and the CCA-end of the P-site transfer RNA (tRNA), thereby stabilizing the peptidyl-tRNA substrate while sterically blocking accommodation of an incoming aminoacyl-tRNA. By clarifying the mode of action of SPA on the bacterial ribosome, our work provides a structural framework for the rational design of SPA derivatives with improved potency and bacterial specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RibosomesSparsomycinProtein Synthesis InhibitorsProtein BiosynthesisThermus thermophilusModels, MolecularRNA, RibosomalCrystallography, X-RayBinding SitesPeptide Chain Elongation, Translational

Substanzen

SparsomycinProtein Synthesis InhibitorsRNA, Ribosomal

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, United States.
  • Université de Bordeaux, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, ARNA, UMR 5320, U1212 Bordeaux, France.
  • Institute of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.
  • Department of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
  • Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60607, United States.
  • Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, United States.

ORCID-Profile: Elodie C Leroy, Egor A Syroegin, Thibaud T Renault, Ronald Micura, C Axel Innis, Yury S Polikanov

Förderung

  • Tyrolean Young Researchers Fund
  • Austrian Science Fund
  • NIGMS NIH HHS
  • European Research Council
  • NIH HHS
  • Illinois State startup funds
  • National Institutes of Health

Zitieren

APA

Paranjpe, M. N., Leroy, E. C., Syroegin, E. A., Flemmich, L., Thaler, J., Gillard, M., Bougas, A., Kournoutou, G., Dinos, G. P., Renault, T. T., Micura, R., Innis, C. A., & Polikanov, Y. S. (2026). Sparsomycin inhibits translation through a conserved mechanism across all domains of life. Nucleic Acids Research, 54(15). https://doi.org/10.1093/nar/gkag761

Vancouver

Paranjpe MN, Leroy EC, Syroegin EA, Flemmich L, Thaler J, Gillard M, et al. Sparsomycin inhibits translation through a conserved mechanism across all domains of life. Nucleic Acids Research. 2026;54(15). doi:10.1093/nar/gkag761

BibTeX
@article{Paranjpe2026,
  author = {Paranjpe, Madhura N and Leroy, Elodie C and Syroegin, Egor A and Flemmich, Laurin and Thaler, Julia and Gillard, Mélanie and Bougas, Anthony and Kournoutou, Georgia and Dinos, George P and Renault, Thibaud T and Micura, Ronald and Innis, C Axel and Polikanov, Yury S},
  title = {Sparsomycin inhibits translation through a conserved mechanism across all domains of life},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {15},
  doi = {10.1093/nar/gkag761}
}
Kostenlos starten →